Osborn Williams & Donohoe’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$3.11M Sell
17,995
-625
-3% -$124K 0.41% 70
2019
Q4
$3.74M Buy
18,620
+625
+3% +$128K 0.37% 74
2019
Q3
$3.8M Buy
17,995
+180
+1% +$37.6K 0.38% 75
2019
Q2
$3.46M Buy
17,815
+840
+5% +$155K 0.36% 81
2019
Q1
$2.9M Buy
+16,975
New +$3M 0.3% 92

Other funds holding CME

Osborn Williams & Donohoe's CME Position: Q1 2020 in Review

Osborn Williams & Donohoe reduced its CME Group (CME) stake by 3.4% in Q1 2020, selling an estimated $124K and leaving 17,995 shares worth $3.11M. The position accounts for 0.41% of the portfolio, ranked #70.

Osborn Williams & Donohoe first reported a position in CME in Q1 2019 and has held it in 5 quarters since. The position peaked at $3.8M in Q3 2019. 1,029 funds tracked by Wall St. Rank hold CME as of Q1 2020.

  • Osborn Williams & Donohoe held 17,995 shares of CME Group worth $3.11M as of Q1 2020.
  • Osborn Williams & Donohoe sold 625 CME Group shares in Q1 2020, an estimated $124K.
  • CME Group made up 0.41% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #70 holding.
  • Osborn Williams & Donohoe first reported a position in CME Group in Q1 2019 and has held it in 5 quarters since.
  • Osborn Williams & Donohoe's CME Group position peaked at $3.8M in Q3 2019.
  • 1,029 funds tracked by Wall St. Rank held CME Group as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.